(Q44431537)

2 December 2017

title

Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05721.X

12 December 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05721.X

12 December 2022

author name string

J. I. Duncan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

C. Horrocks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

A. D. Ormerod

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

A. V. Powles

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

P. H. Whiting

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

L. Fry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

A. W. Thomson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1864010

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1864010

12 December 2022

publication date

1 August 1991

1 reference

full work available at URL

2 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2249.1991.tb05721.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05721.X

https://academic.oup.com/cei/article-pdf/85/2/293/42214331/j.1365-2249.1991.tb05721.x.pdf

12 December 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05721.X

Clinical and Experimental Immunology

12 December 2022

published in

1 reference

2 December 2017

volume

85

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

293-296

1 reference

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

2 December 2017

cites work

1 reference

12 December 2020

Short-term use of cyclosporin A in severe psoriasis

1 reference

12 December 2020

Interleukin-2 and the IL-2 receptor: new insights into structure and function

1 reference

12 December 2020

Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement

1 reference

12 December 2020

Cyclosporin monitoring in psoriasis

1 reference

12 December 2020

Lymphokine gene expression in vivo is inhibited by cyclosporin A.

1 reference

12 December 2020

Epidermal T lymphocytes and HLA-DR expression in psoriasis

1 reference

12 December 2020

Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions

1 reference

12 December 2020

Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis

1 reference

12 December 2020

The effect of tar and ultraviolet on the skin

1 reference

12 December 2020

The released interleukin 2 receptor binds interleukin 2 efficiently

1 reference

12 December 2020

Soluble interleukin-2 receptors in systemic lupus erythematosus

1 reference

12 December 2020

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis

1 reference

12 December 2020

Plasma interleukin 2 receptor levels in renal allograft recipients

1 reference

12 December 2020

The interleukin 2 receptor. Functional consequences of its bimolecular structure

1 reference

12 December 2020

Soluble interleukin 2 receptor in atopic eczema

1 reference

12 December 2020

Reconstitution of a functional IL-2 receptor by the beta-chain cDNA. A newly acquired receptor transduces negative signal

1 reference

12 December 2020

Long-term cyclosporin for psoriasis

1 reference

12 December 2020

Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis

1 reference

12 December 2020

Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity?

1 reference

12 December 2020

The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis

1 reference

12 December 2020

Alteration of lymphocyte functions by 8-methoxypsoralen and long-wave ultraviolet radiation. II. The effect of in vivo PUVA on IL-2 production

1 reference

12 December 2020

Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment

1 reference

12 December 2020

Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05721.X

12 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

2 December 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1864010

12 December 2022

1 reference